Welcome, Guest
Username: Password: Remember me
Adult Stem Cell News and Developments other than Cytori
  • Page:
  • 1

TOPIC: News Coming From Athersys Monday - Should Be Interesting

News Coming From Athersys Monday - Should Be Interesting 01 Jun 2018 12:52 #11894

  • Wall Street Titan
  • Wall Street Titan's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 889
  • Thank you received: 148
For those who do not closely follow Athersys:

As previously announced, on May 1, 2018, Athersys, Inc. (the “Company”) and HEALIOS K.K. (“Healios”) agreed to extend the period from April 30, 2018 to May 31, 2018 to complete their proposed collaboration expansion, as contemplated by the binding letter of intent (the “LOI”) entered into by the parties on March 13, 2018. On May 31, 2018, the Company and Healios agreed to further extend the period for negotiating the collaboration expansion to June 4, 2018. A license fee payment of $10 million held in escrow will be released to the Company today in accordance with the terms of the LOI, which will result in an expansion of the parties’ current license agreement to include acute respiratory distress syndrome (“ARDS”) and ophthamological indications in Japan and organ bud therapies worldwide, as previously disclosed. The Company and Healios are continuing negotiations related to the scope of the collaboration expansion, including the financial terms thereof.

Please Log in or Create an account to join the conversation.

News Coming From Athersys Monday - Should Be Interesting 01 Jun 2018 14:57 #11895

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1333
  • Thank you received: 19

Wall Street Titan wrote: For those who do not closely follow Athersys:

As previously announced, on May 1, 2018, Athersys, Inc. (the “Company”) and HEALIOS K.K. (“Healios”) agreed to extend the period from April 30, 2018 to May 31, 2018 to complete their proposed collaboration expansion, as contemplated by the binding letter of intent (the “LOI”) entered into by the parties on March 13, 2018. On May 31, 2018, the Company and Healios agreed to further extend the period for negotiating the collaboration expansion to June 4, 2018. A license fee payment of $10 million held in escrow will be released to the Company today in accordance with the terms of the LOI, which will result in an expansion of the parties’ current license agreement to include acute respiratory distress syndrome (“ARDS”) and ophthamological indications in Japan and organ bud therapies worldwide, as previously disclosed. The Company and Healios are continuing negotiations related to the scope of the collaboration expansion, including the financial terms thereof.


Surprised that ATHX was not up even more today - looks like VSTM may be done for awhile after that great move up - nice move by CYTX today, up 7% albeit on light volume.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.097 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites